EML4-ALK G1202R mutation induces EMT and confers resistance to ceritinib in NSCLC cells via activation of STAT3/Slug signaling
Jiwei Shen, Yuting Meng, Kunlun Wang, Minghuan Gao, Jianan Du, Junfang Wang, Zengqiang Li, Daiying Zuo, Yingliang Wu
Topics & Concepts
Anaplastic lymphoma kinaseCeritinibCancer researchCrizotinibALK inhibitorSTAT3BiologySignal transductionCell biologyLung cancerMedicinePathologyMalignant pleural effusionLung Cancer Treatments and MutationsLung Cancer Research StudiesCancer therapeutics and mechanisms